Notice of Intent to Grant Exclusive Patent License; SmithKline Beecham Biologicals S.A.

Короткий зміст

The Department of the Navy hereby gives notice of its intent to grant to SmithKline Beecham Biologicals S.A., a revocable, nonassignable, exclusive license in the United States to practice the Government owned invention described in U.S. Patent No. 5,198,535 entitled ``Protective Malaria Sporozoite Surface Protein Immunogen and Gene,'' issued March 30, 1993 in the field of human vaccines to prevent and/or treat malaria based on proteins, polypeptides and/or peptides. Anyone wishing to object to the grant of this license has 60 days from the date of this notice to file written objections along with supporting evidence, if any. Written objections are to be filed with the Office of Naval Research, ONR 00CC, Ballston Tower One, 800 North Quincy Street, Arlington, Virginia 22217-5660.